Teenage Smoking Rate Decreased, but E-cigarette Use Increased

Aug.21.2023
Teenage Smoking Rate Decreased, but E-cigarette Use Increased
Teenage smoking rates decline during COVID-19, but e-cigarette use increases, alcohol consumption remains stable, and mental health deteriorates.

According to a recent survey conducted by the Korea Centers for Disease Control and Prevention (KCDC), the overall smoking rate among teenagers has decreased in the past two years since the outbreak of COVID-19. The survey, titled the "17th Youth Health Behavior Survey," collected data from approximately 60,000 students from middle school first grade to high school third grade between August and November last year.

 

The statistics revealed that the smoking and drinking habits of teenagers remained stable in 2020, after experiencing a significant drop compared to 2019, the year before the COVID-19 pandemic. The percentage of teenagers who reported smoking cigarettes for more than one day in the past month was 4.5%, a similar level to the previous year (4.4%), and lower than the pre-pandemic rate of 6.7% in 2019.

 

The KCDC attributed this trend to the increase in remote learning and the decrease in peer gatherings during the pandemic period. However, the use of e-cigarettes increased, with the usage rates of liquid-type e-cigarettes rising from 1.9% to 2.9% in a year, and cartridge-type e-cigarettes increasing from 1.1% to 1.4%.

 

In terms of alcohol consumption, the percentage of teenagers who reported drinking at least one glass in the past 30 days remained the same at 10.7%. The "current drinking rate" also showed no significant increase since it dropped from 15.0% in 2019 to 10.7% in 2020.

 

While the average alcohol consumption rate in the past month decreased slightly from 5.2% in 2020 to 4.9% in 2021, indicating a decline in risky drinking behaviors, the accessibility to purchase tobacco and alcohol increased. The percentage of teenagers who reported that they could easily buy cigarettes or alcohol from convenience stores or shops increased significantly compared to the previous year, with the accessibility rate for cigarette purchases rising from 67.0% to 74.8% and for alcohol purchases from 63.5% to 71.3%.

 

While the percentage of teenagers engaging in regular physical activities increased slightly to 14.6% who participated in at least 60 minutes of physical activity for five or more days a week, the dietary habits did not improve. The percentage of teenagers skipping breakfast for five or more days a week continued to rise, reaching 38.0% in 2021, compared to 27.9% in 2015. Additionally, the percentage of teenagers consuming fruits decreased for the fifth consecutive year, recording 18.1% in 2021.

 

Mental health indicators also worsened in 2021 compared to the previous year. The prevalence of depression increased from 25.2% in 2020 to 26.8%, and the perceived stress rate rose from 34.2% to 38.8%. Females showed higher rates of depression (31.4%) and stress (45.6%) compared to males (22.4% and 32.3% respectively).

 

In conclusion, while the smoking rate among teenagers has decreased during the COVID-19 pandemic, the use of e-cigarettes has increased. Additionally, there has been no significant change in alcohol consumption, but the accessibility to purchase tobacco and alcohol has increased. Furthermore, despite a slight increase in regular physical activity, detrimental dietary habits and worsening mental health indicators are concerning issues among teenagers.


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
Ohio Supreme Court Weighs Whether State Consumer Law Can Restrict Flavored Vape Sales
Ohio Supreme Court Weighs Whether State Consumer Law Can Restrict Flavored Vape Sales
The Ohio Supreme Court is hearing a case involving flavored vape sales and whether state authorities can use consumer protection laws to take action against retailers selling unauthorized vape products. Ohio officials argue that selling unauthorized flavored vapes may constitute consumer deception, while retailers argue that tobacco product regulation falls under federal Food and Drug Administration (FDA) authority and that states cannot impose additional restrictions through consumer laws. The case could affect the scope of state-level vape regulation across the United States.
Aug.06
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
UAE Sets Dh1-Per-ml Minimum Excise Price for Vape Liquids From Sept. 1 While Keeping 100% Tax Rate
UAE Sets Dh1-Per-ml Minimum Excise Price for Vape Liquids From Sept. 1 While Keeping 100% Tax Rate
The UAE Ministry of Finance will introduce a minimum excise price for e-liquids used in vaping and electronic smoking devices from September 1, 2026. The minimum excise price will be set at AED 1 per millilitre. The existing 100% excise tax rate will continue to apply to tobacco and electronic smoking products. The measure changes the minimum taxable base rather than the tax rate, with the UAE government saying it aims to establish unified tax standards, improve market compliance and prevent pricing loopholes.
Regulations
Aug.07 by 2Firsts Perspectives
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10